<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Alzheimers Dement</journal-id><journal-id journal-id-type="iso-abbrev">Alzheimers Dement</journal-id><journal-title-group><journal-title>Alzheimer's &#x00026; Dementia</journal-title></journal-title-group><issn pub-type="ppub">1552-5260</issn><issn pub-type="epub">1552-5279</issn><publisher><publisher-name>Elsevier, Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5472180</article-id><article-id pub-id-type="publisher-id">S1552-5260(16)30040-1</article-id><article-id pub-id-type="doi">10.1016/j.jalz.2016.09.006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Featured Article</subject></subj-group></article-categories><title-group><article-title>Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wardlaw</surname><given-names>Joanna M.</given-names></name><email>joanna.wardlaw@ed.ac.uk</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author"><name><surname>Makin</surname><given-names>Stephen J.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Vald&#x000e9;s Hern&#x000e1;ndez</surname><given-names>Maria C.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Armitage</surname><given-names>Paul A.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Heye</surname><given-names>Anna K.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Chappell</surname><given-names>Francesca M.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Mu&#x000f1;oz-Maniega</surname><given-names>Susana</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Sakka</surname><given-names>Eleni</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Shuler</surname><given-names>Kirsten</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Dennis</surname><given-names>Martin S.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Thrippleton</surname><given-names>Michael J.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK</aff><aff id="aff2"><label>b</label>Academic Unit of Radiology, Department of Cardiovascular Science, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author. Tel.: + 44 131 465 9599. <email>joanna.wardlaw@ed.ac.uk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>6</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>6</month><year>2017</year></pub-date><volume>13</volume><issue>6</issue><fpage>634</fpage><lpage>643</lpage><permissions><copyright-statement>&#x000a9; 2016 The Authors</copyright-statement><copyright-year>2016</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><sec><title>Introduction</title><p>Small vessel disease (SVD) is a common contributor to dementia. Subtle blood-brain barrier (BBB) leakage may be important in SVD-induced brain damage.</p></sec><sec><title>Methods</title><p>We assessed imaging, clinical variables, and cognition in patients with mild (i.e., nondisabling) ischemic lacunar or cortical stroke. We analyzed BBB leakage, interstitial fluid, and white matter integrity using multimodal tissue-specific spatial analysis around white matter hyperintensities (WMH). We assessed predictors of 1 year cognition, recurrent stroke, and dependency.</p></sec><sec><title>Results</title><p>In 201 patients, median age 67 (range 34&#x02013;97), BBB leakage, and interstitial fluid were higher in WMH than normal-appearing white matter; leakage in normal-appearing white matter increased with proximity to WMH (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.0001), with WMH severity (<italic>P</italic>&#x000a0;=&#x000a0;.033), age (<italic>P</italic>&#x000a0;=&#x000a0;.03), and hypertension (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.0001). BBB leakage in WMH predicted declining cognition at 1 year.</p></sec><sec><title>Discussion</title><p>BBB leakage increases in normal-appearing white matter with WMH and predicts worsening cognition. Interventions to reduce BBB leakage may prevent SVD-associated dementia.</p></sec></abstract><abstract abstract-type="author-highlights" id="abs0015"><title>Highlight</title><p><list list-type="simple"><list-item id="u0010"><label>&#x02022;</label><p>In 201 patients with non-disabling stroke and white matter hyperintensities (WMH), we measured blood-brain barrier (BBB) leakage with contrast-enhanced MRI.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>BBB leakage was higher in WMH than in normal appearing white matter.</p></list-item><list-item id="u0015a"><label>&#x02022;</label><p>BBB leakage increased in both WMH and normal appearing white matter with the burden of small vessel disease, hypertension, and age.</p></list-item><list-item id="u0015s"><label>&#x02022;</label><p>BBB leakage predicted cognitive decline one year later.</p></list-item><list-item id="u0015d"><label>&#x02022;</label><p>The leakage pattern supported the hypothesis that BBB leak was pathogenic of diffuse brain damage in cerebral small vessel disease.</p></list-item></list></p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Blood brain barrier</kwd><kwd>Small vessel disease</kwd><kwd>Stroke</kwd><kwd>White matter hyperintensities</kwd><kwd>Dementia</kwd></kwd-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Worldwide, 36 million people are estimated to be living with dementia <xref rid="bib1" ref-type="bibr">[1]</xref>. Cerebral small vessel disease (SVD) causes about 40% of these dementias, alone or in mixed pathologies <xref rid="bib2" ref-type="bibr">[2]</xref>. SVD also causes a fifth of the 15 million strokes that occur per year worldwide <xref rid="bib1" ref-type="bibr">[1]</xref>. These three-million SVD (or lacunar) strokes are not severe; so, most lacunar stroke patients survive physically independent, but 36% have mild cognitive impairment or dementia <xref rid="bib3" ref-type="bibr">[3]</xref>. The frequent cognitive impairment may reflect the association of lacunar stroke with other SVD features <xref rid="bib4" ref-type="bibr">[4]</xref>. These features (white matter hyperintensities [WMH], lacunes, and microbleeds) are typically regarded as clinically &#x0201c;silent&#x0201d; but substantially increase the risk of dementia and stroke individually <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref> and combined predict cognitive impairment <xref rid="bib8" ref-type="bibr">[8]</xref>.</p><p>Alzheimer's disease (AD) and stroke are typically managed and researched separately, but there is substantial evidence of overlap in pathogenesis, for example, dementia expression in life closely reflects the burden of microvascular disease more than of typical AD pathology (amyloid &#x003b2; plaques and neurofibrillary tangles) at postmortem <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>. WMH are common in AD <xref rid="bib12" ref-type="bibr">[12]</xref>. Management of vascular risk factors <xref rid="bib13" ref-type="bibr">[13]</xref>, lifestyle interventions <xref rid="bib14" ref-type="bibr">[14]</xref>, and stroke prevention <xref rid="bib15" ref-type="bibr">[15]</xref> could help prevent dementia. However, direct application of vascular prevention strategies that are effective in preventing large artery atherothromboembolic stroke may be ineffective or hazardous if given long term to patients with SVD or AD. Thus, blood pressure reduction and dual antiplatelet drugs failed to prevent cognitive decline or recurrent stroke <xref rid="bib16" ref-type="bibr">[16]</xref>, dual versus single antiplatelet drugs were hazardous after lacunar stroke <xref rid="bib17" ref-type="bibr">[17]</xref>, and antiplatelet drugs increased risk of cerebral hemorrhage in AD <xref rid="bib18" ref-type="bibr">[18]</xref>, reflecting our incomplete understanding of mechanisms underlying SVD and AD <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>, and that a different approach is needed <xref rid="bib21" ref-type="bibr">[21]</xref>.</p><p>A potential contributor to, or initiator of, the microvascular damage common to both SVD and AD is cerebral microvessel endothelial (or blood-brain barrier [BBB]) failure <xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>. This could explain the perivascular cell and protein infiltrates, perivascular edema, and secondary axonal and neuronal damage seen pathologically in sporadic SVD <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>. It could also provide a route for entry of amyloid &#x003b2; and inflammatory cells into the brain in AD <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>. Human studies, mostly using cerebrospinal fluid (CSF)/plasma albumin ratio, show that BBB leakage increases subtly with advancing age and is worse in dementia (including AD) than in age-matched controls <xref rid="bib28" ref-type="bibr">[28]</xref>. The BBB is also more leaky in white and deep gray matter in diabetes-associated mild cognitive impairment <xref rid="bib29" ref-type="bibr">[29]</xref>, in white matter and CSF in lacunar than atherothromboembolic stroke <xref rid="bib30" ref-type="bibr">[30]</xref>, and in white matter in patients with leukoaraiosis <xref rid="bib31" ref-type="bibr">[31]</xref>, vascular <xref rid="bib32" ref-type="bibr">[32]</xref>, and Alzheimer's dementias <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>. Recently BBB leakiness was noted to increase in the hippocampus (but not other tissues) with mild cognitive impairment <xref rid="bib35" ref-type="bibr">[35]</xref>.</p><p>These studies of BBB function in&#x000a0;vivo in patients to date have been small (all <italic>n</italic>&#x000a0;&#x0003c;&#x000a0;50 except 1 <xref rid="bib30" ref-type="bibr">[30]</xref>) sampled small volumes of brain <xref rid="bib35" ref-type="bibr">[35]</xref> or used permeability models that ignore aging effects on blood volume and vascular surface area <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref> that limit the measurement of permeability accurately. Thus, there is no comprehensive, whole-brain, tissue-specific, in&#x000a0;vivo assessment of BBB leakiness in human SVD and none with concurrent independent measures of brain interstitial fluid or tissue damage, making it unclear if BBB leakage is real, pathogenic, or an epiphenomenon in SVD. If pathogenic, then we hypothesized that the leak should worsen with worsening SVD burden, be spatially related to major markers of SVD such as WMH, and be accompanied by increased interstitial fluid. BBB leakage should increase with age, in small vessel (i.e., lacunar) versus atherothromboembolic (i.e., cortical or large artery) ischemic stroke <xref rid="bib30" ref-type="bibr">[30]</xref> and in hypertension (a major SVD risk factor <xref rid="bib38" ref-type="bibr">[38]</xref>), and predicts worsening of SVD-associated clinical or imaging features.</p><p>We prospectively studied a large cohort of patients with lacunar stroke (a model for vascular effects on neurodegeneration that identifies patients at high risk of cognitive impairment <xref rid="bib3" ref-type="bibr">[3]</xref>) and cortical ischemic stroke (a control group with similar vascular risk factors <xref rid="bib39" ref-type="bibr">[39]</xref> and medications), with a range of WMH, followed up at 1 year. We&#x000a0;examined the magnitude and spatial distribution of BBB leak and tissue integrity in relation to WMH as a major marker of SVD, using three-dimensional (3D), whole-brain, dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI), diffusion-tensor imaging, T1 mapping, and spatially detailed, tissue-specific analysis.</p></sec><sec id="sec2"><label>2</label><title>Methods</title><sec id="sec2.1"><label>2.1</label><title>Recruitment and eligibility</title><p>We recruited patients prospectively who presented with a lacunar or mild cortical ischemic stroke classified clinically using the risk-factor-free Oxfordshire Community Stroke Project classification <xref rid="bib40" ref-type="bibr">[40]</xref>. We included patients aged &#x02265;18 years, able to consent, within 4 weeks of mild ischemic stroke (i.e., National Institutes of Stroke Scale score [NIHSS] &#x02264;5, unlikely to cause physical dependency), with an MR diffusion-weighted imaging (DWI) infarct compatible with the index stroke symptoms (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>), or no other cause of symptoms, and no life-threatening illness to preclude 1 year follow-up. We excluded patients who were unable to tolerate MRI or gadolinium-containing intravenous contrast agent.<fig id="fig1"><label>Fig.&#x000a0;1</label><caption><p>Magnetic resonance brain imaging sequences and processed images. Left, diffusion-weighted image shows recent small deep infarct in the left centrum semiovale (white area) as the index infarct. Top row, left to right, fluid-attenuated inversion recovery and T2-, T2*-, and T1-weighted axial brain images at the same level as in the large diffusion-weighted image on the left. Bottom row, left to right, colors indicated masking obtained by semiautomated image processing to identify cerebrospinal fluid (yellow), normal-appearing white matter (green), deep gray matter (pink), and white matter hyperintensities (purple); note the index infarct was masked by hand.</p></caption><graphic xlink:href="gr1"/></fig></p></sec><sec id="sec2.2"><label>2.2</label><title>Ethics</title><p>Lothian Ethics of Medical Research Committee (REC 09/81,101/54) and NHS Lothian R+D Office (2009/W/NEU/14) approved the study. All patients gave written informed consent.</p></sec><sec id="sec2.3"><label>2.3</label><title>Clinical assessments and outcomes</title><p>A specialist stroke physician recorded the medical history and examination including stroke severity (NIHSS, for details, see <xref rid="appsec1" ref-type="sec">Supplementary Material</xref>). A panel of stroke experts assigned the stroke subtype (lacunar or cortical) using the clinical syndrome <xref rid="bib40" ref-type="bibr">[40]</xref> and acute infarct appearance on DWI MRI. In case of discrepancies, the imaging subtype was used.</p><p>We introduced cognitive testing after the study had started and assessed current cognition in as many patients as possible thereafter (Addenbrooke Cognitive Assessment&#x02014;Revised [ACE-R]), premorbid intelligence (National Adult Reading Test [NART]), and depression (Beck Depression Index) at 1&#x02013;3&#x000a0;months after stroke concurrent with BBB imaging (Section 2.4 below).</p><p>At 1 year, we assessed all patients for dependency (Oxford Handicap Scale <xref rid="bib41" ref-type="bibr">[41]</xref>, similar to the modified Rankin Scale), recurrent vascular events, cognition (ACE-R), and repeated MRI for WMH burden, new infarcts, or hemorrhages. Patients unable to attend were followed up remotely.</p></sec><sec id="sec2.4"><label>2.4</label><title>Neuroimaging</title><p>All MR examinations were performed on one 1.5-T&#x000a0;GE Signa HDxt scanner, with tight quality assurance. Diagnostic MR included T1, T2, T2*, and DTI sequences (see <xref rid="appsec1" ref-type="sec">&#x0201c;Online Methods&#x0201d; and Supplementary Table 1 in Supplementary Material</xref>
<xref rid="bib42" ref-type="bibr">[42]</xref>) to assess infarcts and SVD features <xref rid="bib43" ref-type="bibr">[43]</xref>. We performed DCE MRI <xref rid="bib37" ref-type="bibr">[37]</xref> for BBB leak at 1&#x02013;3&#x000a0;months after stroke (to minimize the index stroke effect on BBB) and T1 mapping for brain water content (see <xref rid="appsec1" ref-type="sec">Supplementary Material</xref>). After two 3D fast-spoiled gradient-echo acquisitions (flip angles 2 and 12&#x000b0;) for precontrast T1 (T<sub>10</sub>) maps, we injected gadoterate meglumine (Gd-DOTA, DOTAREM; Guerbet, Paris, France) 0.2&#x000a0;mL/kg (i.e., 0.1&#x000a0;mmol/kg body weight) at 2&#x000a0;mL/second intravenously via injection pump and then repeated the 3D T1-weighted sequence sequentially 20 times for 24&#x000a0;minutes <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, using long acquisition times to detect subtle BBB leak <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>.</p></sec><sec id="sec2.5"><label>2.5</label><title>Image processing</title><p>We analyzed all imaging data blind to clinical and other imaging information using validated, qualitative, and quantitative assessments (see <xref rid="appsec1" ref-type="sec">&#x0201c;Online Methods&#x0201d; in Supplementary Material</xref>
<xref rid="bib42" ref-type="bibr">[42]</xref>), as previously <xref rid="bib45" ref-type="bibr">[45]</xref>. We identified the index infarct and SVD lesions using visual scores (see <xref rid="appsec1" ref-type="sec">&#x0201c;Online Methods&#x0201d; in Supplementary Material</xref>). On coregistered images, we separated CSF, whole-brain, WMH, and normal-appearing white and gray matter <xref rid="bib46" ref-type="bibr">[46]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref> (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>), differentiating WMH into &#x0201c;more&#x0201d; and &#x0201c;less&#x0201d; intense by degree of abnormality on fluid-attenuated inversion recovery and T2 and T1 sequences. For spatial analysis of BBB leak distribution, we also divided normal-appearing white matter into 10 &#x0201c;contours&#x0201d; each two voxels (&#x02248;2&#x000a0;mm) wide from the WMH edge outward (piloted in <xref rid="bib48" ref-type="bibr">[48]</xref>). We extracted signal intensities from the DCE-MRI pre-post contrast curves per tissue, per voxel, and per time point after intravenous contrast (see <xref rid="appsec1" ref-type="sec">&#x0201c;Online Methods&#x0201d; in Supplementary Material</xref>) <xref rid="bib44" ref-type="bibr">[44]</xref>. We used sagittal sinus to correct for intravascular contrast <xref rid="bib44" ref-type="bibr">[44]</xref> as carotid arteries have significant limitations especially in older subjects <xref rid="bib37" ref-type="bibr">[37]</xref>. We calculated precontrast T1 (longitudinal relaxation time, T<sub>10</sub>
<xref rid="bib44" ref-type="bibr">[44]</xref>, milliseconds) to control for precontrast tissue characteristics <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>.</p></sec><sec id="sec2.6"><label>2.6</label><title>Sample size</title><p>For 80% power, a two-sided test, the estimated sample size was 170 patients to reach 1 year follow-up. Allowing for about 10% dropout required 200 patients to have BBB imaging (see <xref rid="appsec1" ref-type="sec">&#x0201c;Online Methods&#x0201d; in Supplementary Material</xref>).</p></sec><sec id="sec2.7"><label>2.7</label><title>Statistical analysis</title><p>Several mathematical models have been proposed to estimate BBB permeability <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>. The Patlak method best suits low permeability states <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib49" ref-type="bibr">[49]</xref>, <xref rid="bib50" ref-type="bibr">[50]</xref>, but all models rely on assumptions regarding capillary surface area that are invalid in low permeability states, for example, that capillary density and blood volume are constant, whereas both vary between tissues and decrease with age and in disease <xref rid="bib37" ref-type="bibr">[37]</xref>. In the individual tissues and subjects, the actual capillary density is unknown, and it would introduce further potential confounds to use constant values. We explored permeability modeling methods extensively, including in simulations <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, tried to obtain estimates of capillary density to provide realistic factors, but none of these were adequate for use in a wide age range and disease range population such as here. We found strong effects of age on BBB, T1, mean diffusivity (MD), and fractional anisotropy (FA) in separate analyses <xref rid="bib47" ref-type="bibr">[47]</xref>, <xref rid="bib48" ref-type="bibr">[48]</xref>. Therefore, in our prespecified analysis (see <xref rid="appsec1" ref-type="sec">&#x0201c;Protocol Online&#x0201d; in Supplementary Material</xref>), we did not calculate permeability but used linear mixed modeling of the signal enhancement slopes (<xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>) to identify tissue- and patient-specific differences in BBB leakage. All BBB analyses were adjusted for age, WMH burden, vascular risk factors, intravascular contrast, baseline tissue T1, and time after contrast injection (full statistical details, see <xref rid="appsec1" ref-type="sec">&#x0201c;Online Methods&#x0201d; in Supplementary Material</xref>). Analysis of ACE-R also tested for interactions between lacunar and cortical subtypes. We used SAS 9.3 (<ext-link ext-link-type="uri" xlink:href="http://www.sas.com/" id="intref0010">www.sas.com</ext-link>) for all analyses and R 2.13.1 for graphs.<fig id="fig2"><label>Fig.&#x000a0;2</label><caption><p>Change in signal postcontrast in different brain tissues by time averaged across all patients. The graph demonstrates that signal in the blood pool declines after the first pass of bolus but increases progressively in all brain tissues meaning that intravascular contrast does not account for the tissue signal changes. NAWM, normal appearing white matter; WMH, white matter hyperintensities; DGM, deep gray matter; NSL, new (index) stroke lesion; SS, sagittal sinus (represents the blood pool and provides an arterial input function for statistical modeling purposes).</p></caption><graphic xlink:href="gr2"/></fig></p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><p>We recruited 264 patients (<xref rid="appsec1" ref-type="sec">Supplementary Fig.&#x000a0;1</xref>): 42 declined detailed MRI, 14 were not well enough for BBB imaging, and BBB or structural data were insufficient for analysis in 7, leaving 201 with complete data. The 63 patients without BBB imaging had slightly more severe strokes (median NIHSS 2, interquartile range [IQR] 2&#x02013;4) than the 201 with BBB imaging (NIHSS 2, IQR 1&#x02013;3, <italic>P</italic>&#x000a0;=&#x000a0;.03) and were slightly older (66 vs 69&#x000a0;years, <italic>P</italic>&#x000a0;=&#x000a0;.025), but there were no other differences.</p><p>The 92 of 201 (46%) patients with lacunar stroke did not differ significantly from the 109 (54%) with cortical stroke in age (mean: 64, IQR 56&#x02013;72; 68, IQR 60&#x02013;76, respectively, <italic>P</italic>&#x000a0;=&#x000a0;.097) proportion of men, with hypertension, diabetes, or hyperlipidemia (<xref rid="appsec1" ref-type="sec">Supplementary Table&#x000a0;2</xref>). Lacunar strokes were more severe than cortical strokes (NIHSS medians: 1, IQR 0&#x02013;2; vs 1, IQR 0&#x02013;1, respectively, <italic>P</italic>&#x000a0;=&#x000a0;.002), with no difference in time to initial assessment (medians: 3, 1&#x02013;6; vs 3, 1&#x02013;8&#x000a0;days, respectively, <italic>P</italic>&#x000a0;=&#x000a0;.71). Cortical patients had more embolic sources than lacunar (25.7% vs 12%, <italic>P</italic>&#x000a0;=&#x000a0;.014). Cognitive testing was available for 147 (73%) at 1&#x02013;3&#x000a0;months (median ACE-R, 90, IQR 83&#x02013;95) and in 139 (69%) at 1 year (median ACE-R 92, IQR 85&#x02013;95).</p><p>Compared with normal-appearing white matter, BBB leakage was higher in WMH (<italic>P</italic>&#x000a0;=&#x000a0;.025), CSF (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.0001), index (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.0001), and old infarcts (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.0001) and was lower in deep gray matter (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.0001, <xref rid="appsec1" ref-type="sec">Supplementary Table&#x000a0;3</xref>, <xref rid="fig2" ref-type="fig">Fig.&#x000a0;2</xref>). BBB leakage increased with (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>) age in all tissues, significantly in deep gray, CSF, and WMH, for example, in deep gray matter by 0.025 &#x000d7; 10<sup>3</sup> (95% confidence interval [CI] 0.0023 &#x000d7; 10<sup>3</sup>, 0.049 &#x000d7; 10<sup>3</sup>, <italic>P</italic>&#x000a0;=&#x000a0;.030), per 5-year age increment; WMH burden, significantly in all tissues except index or old infarcts, for example, in normal-appearing white matter by 0.024 &#x000d7; 10<sup>3</sup>, (95% CI 0.002 &#x000d7; 10<sup>3</sup>, 0.047 &#x000d7; 10<sup>3</sup>, <italic>P</italic>&#x000a0;=&#x000a0;.033), per point increase in WMH score; and in index and old infarcts of cortical versus lacunar subtype. BBB leakage was significantly higher in lacunar than cortical subtype in CSF but in cortical than lacunar stroke in normal-appearing white matter and deep gray matter. BBB leakage also increased with (<xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>): hypertension significantly in all tissues, pulse pressure in some tissues, and with baseline tissue T1 (i.e., water content) in all tissues.<table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>BBB leakage and age, WMH burden (Fazekas score), and stroke subtype</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Tissue</th><th>Variable</th><th>&#x003b2; coefficient &#x000d7; 10<sup>3</sup></th><th>95% CI &#x000d7; 10<sup>3</sup></th><th><italic>P</italic>-value</th></tr></thead><tbody><tr><td rowspan="3">Normal-appearing white matter</td><td>Age</td><td align="char">0.016</td><td>&#x02212;0.001, 0.033</td><td align="char">.065</td></tr><tr><td>Fazekas score</td><td align="char">0.024</td><td>0.002, 0.047</td><td align="char">.033</td></tr><tr><td>Stroke subtype</td><td align="char">&#x02212;0.110</td><td>&#x02212;0.19, &#x02212;0.030</td><td align="char">.005</td></tr><tr><td rowspan="3">Deep gray matter</td><td>Age</td><td align="char">0.025</td><td>0.002, 0.049</td><td align="char">.031</td></tr><tr><td>Fazekas score</td><td align="char">0.059</td><td>0.028, 0.09</td><td align="char">.0002</td></tr><tr><td>Stroke subtype</td><td align="char">&#x02212;0.11</td><td>&#x02212;0.21, &#x02212;0.0003</td><td align="char">.049</td></tr><tr><td rowspan="3">CSF</td><td>Age</td><td align="char">0.219</td><td>0.158, 0.28</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Fazekas score</td><td align="char">0.205</td><td>0.124, 0.287</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Stroke subtype</td><td align="char">0.363</td><td>0.082, 0.644</td><td align="char">.011</td></tr><tr><td rowspan="3">WMH</td><td>Age</td><td align="char">0.059</td><td>0.035, 0.082</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Fazekas score</td><td align="char">0.104</td><td>0.072, 0.136</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Stroke subtype</td><td align="char">&#x02212;0.040</td><td>&#x02212;0.150, 0.068</td><td align="char">.46</td></tr><tr><td rowspan="3">Index infarct</td><td>Age</td><td align="char">0.045</td><td>0.001, 0.089</td><td align="char">.045</td></tr><tr><td>Fazekas score</td><td align="char">0.017</td><td>&#x02212;0.040, 0.075</td><td align="char">.57</td></tr><tr><td>Stroke subtype</td><td align="char">&#x02212;0.520</td><td>&#x02212;0.720, &#x02212;0.330</td><td align="char">&#x0003c;.0001</td></tr><tr><td rowspan="3">Old infarct</td><td>Age</td><td align="char">0.049</td><td>&#x02212;0.0015, 0.10</td><td align="char">.057</td></tr><tr><td>Fazekas score</td><td align="char">0.041</td><td>&#x02212;0.030, 0.11</td><td align="char">.24</td></tr><tr><td>Stroke subtype</td><td align="char">&#x02212;0.430</td><td>&#x02212;0.680, &#x02212;0.190</td><td align="char">.0004</td></tr></tbody></table><table-wrap-foot><fn id="tspara0015"><p>Abbreviations: BBB, blood-brain barrier; WMH, white matter hyperintensities; CI, confidence interval; CSF, cerebrospinal fluid.</p></fn><fn id="tspara0020"><p>NOTE. Values are BBB leakage (change in postcontrast signal per minute) per 5-year increase in age, per point increase in Fazekas score, or lacunar versus cortical stroke. The interaction coefficients for age, Fazekas score, and subtype are derived from three separate models (the data were already adjusted for key predictors listed previously and simultaneous fitting of multiple interaction terms was not supported). Age, Fazekas score, and stroke subtype are each adjusted for each other and sagittal sinus signal, brain tissue signal precontrast (T<sub>10</sub>), mean arterial blood pressure, diagnosis of hypertension, pulse pressure, and smoker status. In stroke subtype, a negative effect estimate indicates that values are lower in patients with lacunar than with cortical stroke. A higher Fazekas score indicates more WMH.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table&#x000a0;2</label><caption><p>Association between BBB leakage, vascular risk factors, and brain parameters: hypertension, mean arterial pressure, smoker status, brain tissue T1 signal precontrast, and intravascular signal (sagittal sinus), adjusted for one another, age, and combined Fazekas score</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Tissue</th><th>Variable</th><th>&#x003b2; coefficient &#x000d7; 10<sup>3</sup></th><th>95% CI &#x000d7; 10<sup>3</sup></th><th><italic>P</italic>-value</th></tr></thead><tbody><tr><td rowspan="6">Normal-appearing white matter</td><td>Hypertension</td><td align="char">0.206</td><td>0.118, 0.295</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Mean arterial pressure</td><td align="char">&#x02212;0.00105</td><td>&#x02212;0.0036, 0.0015</td><td align="char">.41</td></tr><tr><td>Pulse pressure</td><td align="char">0.00121</td><td>&#x02212;0.00061, 0.0030</td><td align="char">.19</td></tr><tr><td>Smoking status</td><td align="char">&#x02212;0.050</td><td>&#x02212;0.130, 0.026</td><td align="char">.18</td></tr><tr><td>Tissue T1</td><td align="char">0.46</td><td>0.153, 0.768</td><td align="char">.0033</td></tr><tr><td>Intravascular contrast</td><td align="char">0.050</td><td>&#x02212;0.080, 0.181</td><td align="char">.45</td></tr><tr><td rowspan="6">Deep gray matter</td><td>Hypertension</td><td align="char">0.233</td><td>0.111, 0.354</td><td align="char">.0002</td></tr><tr><td>Mean arterial pressure</td><td align="char">0.00017</td><td>&#x02212;0.0033, 0.0036</td><td align="char">.93</td></tr><tr><td>Pulse pressure</td><td align="char">0.00380</td><td>0.0013, 0.0063</td><td align="char">.003</td></tr><tr><td>Smoking status</td><td align="char">0.035</td><td>&#x02212;0.080, 0.146</td><td align="char">.53</td></tr><tr><td>Tissue T1</td><td align="char">0.365</td><td>&#x02212;0.0018, 0.732</td><td align="char">.051</td></tr><tr><td>Intravascular contrast</td><td align="char">0.00062</td><td>&#x02212;0.180, 0.182</td><td align="char">.99</td></tr><tr><td rowspan="6">CSF</td><td>Hypertension</td><td align="char">0.338</td><td>0.016, 0.66</td><td align="char">.040</td></tr><tr><td>Mean arterial pressure</td><td align="char">0.016</td><td>0.0064, 0.025</td><td align="char">.0009</td></tr><tr><td>Pulse pressure</td><td align="char">0.017</td><td>0.011, 0.024</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Smoking status</td><td align="char">&#x02212;0.30</td><td>&#x02212;0.590, &#x02212;0.010</td><td align="char">.042</td></tr><tr><td>Tissue T1</td><td align="char">1.107</td><td>0.903, 1.31</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Intravascular contrast</td><td align="char">1.363</td><td>0.878, 1.848</td><td align="char">&#x0003c;.0001</td></tr><tr><td rowspan="6">WMH</td><td>Hypertension</td><td align="char">0.256</td><td>0.131, 0.38</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Mean arterial pressure</td><td align="char">0.000368</td><td>&#x02212;0.0032, 0.0039</td><td align="char">.84</td></tr><tr><td>Pulse pressure</td><td align="char">0.00333</td><td>0.00076, 0.00589</td><td align="char">.011</td></tr><tr><td>Smoking status</td><td align="char">&#x02212;0.110</td><td>&#x02212;0.23, 0.0002</td><td align="char">.050</td></tr><tr><td>Tissue T1</td><td align="char">0.536</td><td>0.163, 0.909</td><td align="char">.0049</td></tr><tr><td>Intravascular contrast</td><td align="char">0.237</td><td>0.052, 0.423</td><td align="char">.012</td></tr><tr><td rowspan="6">Index infarct</td><td>Hypertension</td><td align="char">0.677</td><td>0.444, 0.91</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Mean arterial pressure</td><td align="char">&#x02212;0.00298</td><td>&#x02212;0.009, 0.003</td><td align="char">.35</td></tr><tr><td>Pulse pressure</td><td align="char">&#x02212;0.00203</td><td>&#x02212;0.0066, 0.0025</td><td align="char">.38</td></tr><tr><td>Smoking status</td><td align="char">&#x02212;0.040</td><td>&#x02212;0.240, 0.154</td><td align="char">.67</td></tr><tr><td>Tissue T1</td><td align="char">1.617</td><td>1.249, 1.984</td><td align="char">&#x0003c;.0001</td></tr><tr><td>Intravascular contrast</td><td align="char">&#x02212;0.040</td><td>&#x02212;0.390, 0.305</td><td align="char">.81</td></tr><tr><td rowspan="6">Old infarct</td><td>Hypertension</td><td align="char">0.472</td><td>0.208, 0.735</td><td align="char">.0005</td></tr><tr><td>Mean arterial pressure</td><td align="char">0.016</td><td>0.007, 0.024</td><td align="char">.0002</td></tr><tr><td>Pulse pressure</td><td align="char">0.00261</td><td>&#x02212;0.0033, 0.0085</td><td align="char">.39</td></tr><tr><td>Smoking status</td><td align="char">&#x02212;0.40</td><td>&#x02212;0.64, &#x02212;0.16</td><td align="char">.001</td></tr><tr><td>Tissue T1</td><td align="char">0.773</td><td>0.317, 1.228</td><td align="char">.001</td></tr><tr><td>Intravascular contrast</td><td align="char">0.086</td><td>&#x02212;0.330, 0.499</td><td align="char">.68</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: BBB, blood-brain barrier; CI, confidence interval; CSF, cerebrospinal fluid; WMH, white matter hyperintensities.</p></fn></table-wrap-foot></table-wrap></p><p>Analysis of spatial distribution of BBB leakage in normal-appearing white matter (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>) showed that BBB leakage increased linearly at 0.0099 &#x000d7; 10<sup>3</sup> (95% CI 0.0114 &#x000d7; 10<sup>3</sup>, 0.0084 &#x000d7; 10<sup>3</sup>, <italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.0001) per contour closer to the WMH edge, adjusted for age, Fazekas score, blood pressure, stroke subtype, and smoking. The leak was worst in the WMH where it was worst in the most abnormal areas (&#x0201c;intense&#x0201d; versus &#x0201c;less intense&#x0201d; WMH). Additionally, MD increased from the 4&#x000a0;mm contour and T1 from the 2&#x000a0;mm contour proximate to the WMH edge; both were yet higher in less intense and highest in intense WMH (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>), consistent with an increase in interstitial water mobility and then in measureable interstitial water close to the WMH, with the most abnormal values in the WMH. Axonal integrity (FA) decreased with increasing proximity to WMH, being lowest in the most intense WMH, consistent with most axonal disruption being in the most abnormal-looking tissue.<fig id="fig3"><label>Fig.&#x000a0;3</label><caption><p>Representative axial brain magnetic resonance imaging (left, same case as in <xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>) showing white matter hyperintensities and contours at two voxel increments (approximately 2&#x000a0;mm width) extending concentrically into the normal-appearing white matter from which blood-brain barrier leakage (Pby, graph top left), mean diffusivity (graph top right, &#x000d7;10<sup>&#x02212;9</sup> mm<sup>2</sup>/s), fractional anisotropy (graph bottom left), and T1 (graph bottom right, ms) were extracted. White matter hyperintensities are split into intense and less intense to determine the difference in these biomarkers by severity of white matter hyperintensities and by all white matter hyperintensities, as indicated on the x-axis. WMH, white matter hyperintensities; FA, fractional anisotropy; iWMH, intense white matter hyperintensities; liWMH, less intense white matter hyperintensities.</p></caption><graphic xlink:href="gr3"/></fig></p><p>On further assessing the contours by Fazekas WMH score corrected for age (<xref rid="fig4" ref-type="fig">Fig.&#x000a0;4</xref>), patients with most WMH (Fazekas score 5&#x02013;6) had the highest BBB leakage, water content (MD, T1), and lowest axonal integrity (FA) in normal-appearing white matter and WMH (for details, see <xref rid="appsec1" ref-type="sec">Supplementary Fig.&#x000a0;2</xref>).<fig id="fig4"><label>Fig.&#x000a0;4</label><caption><p>Changes in blood-brain barrier leakage (top left, Pby), mean diffusivity (top right, &#x000d7;10<sup>&#x02212;9</sup>&#x000a0;mm<sup>2</sup>/s), fractional anisotropy (bottom left), and T1 (bottom right, ms) in white matter hyperintensities and 2&#x000a0;mm incremental contours expanding concentrically across normal-appearing white matter, according to white matter hyperintensities burden categorized by Fazekas score into low (0&#x02013;2), medium (3&#x02013;4), and high (5&#x02013;6) white matter hyperintensities burden. Contours as in <xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>, left-hand image. <xref rid="appsec1" ref-type="sec">Supplementary Fig.&#x000a0;3</xref> shows these data by individual Fazekas white matter hyperintensities scores. Data are age adjusted. Faz_group, Fazekas score group; WMH, white matter hyperintensities; MD, mean diffusivity; iWMH, intense white matter hyperintensities; LiWMH, less intense white matter hyperintensities; FA, fractional anisotropy.</p></caption><graphic xlink:href="gr4"/></fig></p><p>At 1&#x02013;3&#x000a0;months after stroke, ACE-R was associated negatively with age and positively with premorbid intelligence (NART), but not with WMH score or concurrent BBB leakage in any tissues, with no difference between lacunar and cortical stroke patients (<xref rid="appsec1" ref-type="sec">Supplementary Table&#x000a0;4</xref>). At 1 year, BBB leakage in WMH predicted lower ACE-R in lacunar (&#x003b2; &#x02212;3.52, 95% CI &#x02212;5.9, &#x02212;1.13) but not cortical (&#x003b2; 0.03, 95% CI &#x02212;5.77, 5.12) stroke patients; high WMH score and NART, but not age, predicted ACE-R in both stroke subtypes (<xref rid="appsec1" ref-type="sec">Supplementary Table&#x000a0;5</xref>). Incorporating ACE-R at 1&#x02013;3&#x000a0;months after stroke into the 1-year ACE-R prediction model (to assess change in ACE-R and BBB leak) showed that BBB leakage in WMH predicted a decline in ACE-R at 1 year in both lacunar and cortical stroke patients (&#x003b2; &#x02212;1.89, 95% CI &#x02212;3.62, &#x02212;0.16). ACE-R and NART at 1&#x02013;3&#x000a0;months also predicted decline in ACE-R at 1 year (<xref rid="appsec1" ref-type="sec">Supplementary Table&#x000a0;6</xref>) but not WMH score, hypertension, or age.</p><p>At 1 year, 21 patients had a clinically evident recurrent stroke, 19 had a new infarct on MRI (21 of 201 could not have repeat scanning, <xref rid="appsec1" ref-type="sec">Supplementary Fig.&#x000a0;1</xref>), and 34 patients were dependent or dead (17%). WMH burden was the strongest predictor of recurrent stroke or dependency, overwhelming BBB associations except for BBB leakage in CSF that showed a weak association with dependency (<xref rid="appsec1" ref-type="sec">Supplementary Table&#x000a0;7</xref>). Vascular risk factors did not predict outcome.</p></sec><sec id="sec4"><label>4</label><title>Discussion</title><p>We show, in this large stratified patient cohort, that subtle increases in BBB leakage appear to be widespread in normal-appearing white matter and more pronounced in WMH, increasing with the visible severity of tissue damage. The BBB leak is accompanied by increased interstitial water mobility and water content close to and in the WMH, providing support for the BBB leak findings. BBB leakage in normal-appearing white matter and in WMH was worst in patients with severe WMH, with hypertension and increased pulse pressure. BBB leakage in WMH predicted cognitive impairment at 1 year in lacunar stroke and cognitive decline between 1 and 3&#x000a0;months and 1 year after stroke in both lacunar and cortical stroke patients. Taken together, these observations suggest that BBB leakage precedes increases in interstitial fluid and axonal damage, all which worsen as WMH worsen; BBB leak in WMH also predicts cognitive decline at 1 year, particularly in lacunar stroke patients who are already known to be at high risk of cognitive decline after stroke <xref rid="bib3" ref-type="bibr">[3]</xref>. We show that WMH associate with BBB leakage regardless of the underlying stroke subtype, findings that are generalizable to older subjects with WMH. Thus, BBB leakage appears to be important in pathogenesis of SVD-associated brain damage in large clinical populations. The association between BBB leak, hypertension, and pulse pressure provides a mechanism whereby hypertension may worsen WMH <xref rid="bib38" ref-type="bibr">[38]</xref> and thus may contribute to declining cognition. Pathogenesis involving BBB leak may also explain the apparent lack of benefit for antithrombotic drugs and increased hemorrhage risk in SVD <xref rid="bib17" ref-type="bibr">[17]</xref>, <xref rid="bib51" ref-type="bibr">[51]</xref> and AD <xref rid="bib18" ref-type="bibr">[18]</xref>.</p><p>We provide conclusive in&#x000a0;vivo evidence that normal-appearing white matter, in the presence of WMH, is not normal, at any adult age, but increasingly abnormal with increasing WMH burden <xref rid="bib48" ref-type="bibr">[48]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref> and by proximity to WMH <xref rid="bib52" ref-type="bibr">[52]</xref>, <xref rid="bib53" ref-type="bibr">[53]</xref>. In comparison with recent work <xref rid="bib52" ref-type="bibr">[52]</xref>, our study provides more extensive spatial sampling of brain white matter and multiple independent imaging parameters. We show, in this much larger sample, that subtle BBB failure can be detected with DCE MRI in large clinical studies. In comparison with recent work <xref rid="bib35" ref-type="bibr">[35]</xref>, our study provides full brain coverage, volumetric analysis of BBB leakage across spatially related tissue while preserving sensitivity to low-grade BBB leak <xref rid="bib37" ref-type="bibr">[37]</xref>, a large, highly phenotyped, clinically relevant patient sample, and assumption-free statistical analysis. This approach was based on extensive testing of models including simulated data which made it clear that current models were not suitable for low permeability states across a wide range of age and disease <xref rid="bib37" ref-type="bibr">[37]</xref>. The differences in BBB leakage in index and old infarcts demonstrate the sensitivity of this method to detect BBB leakage.</p><p>Why should increased BBB leakage occur in SVD and is this also relevant to AD? AD and SVD pathologies commonly co-occur, cognition is worse when SVD is present in AD <xref rid="bib12" ref-type="bibr">[12]</xref>, vascular risk factors accelerate both disorders, both are associated with elevated systemic inflammatory markers, and microglial activation is common in both diseases pathologically. The BBB has a huge surface area, handles a fifth of the cardiac output at rest, and maintains the correct brain interstitial milieu within tight limits for normal brain function, a major physiological challenge <xref rid="bib2" ref-type="bibr">[2]</xref>. A slight decline in barrier function could result in vascular wall and perivascular parenchymal damage from fluid shifts <xref rid="bib54" ref-type="bibr">[54]</xref> or allow neurotoxins such as serum amyloid P, an important precursor to amyloid deposition <xref rid="bib27" ref-type="bibr">[27]</xref>, into the brain. The findings are consistent with BBB failure being an early pathogenic step in SVD, with axonal loss occurring secondarily <xref rid="bib54" ref-type="bibr">[54]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>. BBB integrity declines with normal aging and is worse in AD according to biochemical <xref rid="bib28" ref-type="bibr">[28]</xref> and pathological <xref rid="bib33" ref-type="bibr">[33]</xref> analyses. BBB failure may occur through multiple factors, for example, hypertension, diabetes, inflammation <xref rid="bib24" ref-type="bibr">[24]</xref>, smoking, and increased sodium intake <xref rid="bib50" ref-type="bibr">[50]</xref>, all damage the vascular endothelium. Cerebral blood flow is reduced in both SVD and AD: hypoperfusion triggers BBB failure in experimental models, and fibrinogen leakage across the BBB was associated with astrocyte morphological changes, reversal of aquaporin 4 distribution on end feet implying glyovascular malfunction, and irreversible damage in WMH seen at postmortem in patients with cognitive impairment after stroke in life <xref rid="bib55" ref-type="bibr">[55]</xref>. WMH heritability <xref rid="bib56" ref-type="bibr">[56]</xref> and genetics <xref rid="bib57" ref-type="bibr">[57]</xref> suggest that some individuals may be more susceptible to damage in the neurovascular unit, including the BBB <xref rid="bib58" ref-type="bibr">[58]</xref>, perhaps accounting for variation in SVD-related brain damage and clinical expression between individuals with apparently similar risk factor exposures.</p><p>Our results provide evidence that BBB leakage is an important, likely early pathological event in development of SVD-associated brain damage. WMH should sound alarm bells to identify potentially modifiable risk factors at all ages and in all dementias. Brain interstitial fluid shifts are potentially remediable, at least initially: reduction in interstitial fluid, for example, by improved endothelial function and reduced BBB leak, might prevent accumulation of permanent brain injury, slowing neurodegeneration, preserving cognition, and preventing dementia and stroke. Persistent BBB malfunction may precipitate worsening of microvessel wall injury, with secondary inflammation <xref rid="bib24" ref-type="bibr">[24]</xref>, impaired vasoreactivity <xref rid="bib59" ref-type="bibr">[59]</xref>, or luminal narrowing and hence tissue ischemia&#x02014;a vicious cycle of brain damage. Future research should target ways to reduce small vessel endothelial damage to prevent progressive BBB breakdown and brain injury including, but not restricted to, improved management of lifestyle factors (e.g., exercise <xref rid="bib14" ref-type="bibr">[14]</xref>, diet <xref rid="bib50" ref-type="bibr">[50]</xref>) and vascular risk factors (e.g., hypertension).<boxed-text id="dtbox1"><caption><title>Research in Context</title></caption><p><list list-type="simple"><list-item id="o0010"><label>1.</label><p>Systematic review: We reviewed the literature on blood-brain barrier (BBB) leakage detected with magnetic resonance imaging in humans during aging, in small vessel disease (SVD) or dementia, from multiple electronic bibliographic databases and identified six studies (<italic>n</italic>&#x000a0;=&#x000a0;203).</p></list-item><list-item id="o0015"><label>2.</label><p>Interpretation: Our study doubles the available data on BBB leakage and provides independent evidence on the hypothesis that BBB leakage is pathogenic in SVD-related brain damage including tissue fluid measures, spatial distribution, two SVD markers, age, disease burden, risk factor (hypertension), and cognition associations.</p></list-item><list-item id="o0020"><label>3.</label><p>Future directions: Our results provide a testable hypothesis, a route for amyloid entry to the brain, and should encourage new thinking about SVD and/or aging-related brain damage and cognitive decline beyond ischemia or amyloid deposition. Future research should focus on the many lifestyle and risk factor&#x02013;modifying interventions that could protect the cerebrovascular endothelium and developing new specific drugs to preserve or enhance BBB function.</p></list-item></list></p></boxed-text></p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Lozano</surname><given-names>R.</given-names></name><name><surname>Naghavi</surname><given-names>M.</given-names></name><name><surname>Foreman</surname><given-names>K.</given-names></name><name><surname>Lim</surname><given-names>S.</given-names></name><name><surname>Shibuya</surname><given-names>K.</given-names></name><name><surname>Aboyans</surname><given-names>V.</given-names></name></person-group><article-title>Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010</article-title><source>Lancet</source><volume>380</volume><year>2013</year><fpage>2095</fpage><lpage>2128</lpage></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Iadecola</surname><given-names>C.</given-names></name></person-group><article-title>The pathobiology of vascular dementia</article-title><source>Neuron</source><volume>80</volume><year>2013</year><fpage>844</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">24267647</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Makin</surname><given-names>S.</given-names></name><name><surname>Turpin</surname><given-names>S.</given-names></name><name><surname>Dennis</surname><given-names>M.</given-names></name><name><surname>Wardlaw</surname><given-names>J.</given-names></name></person-group><article-title>Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke sub-types</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>84</volume><year>2013</year><fpage>893</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">23457225</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Valdes Hernandez</surname><given-names>M.C.</given-names></name><name><surname>Maconick</surname><given-names>L.C.</given-names></name><name><surname>Munoz Maniega</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Wiseman</surname><given-names>S.</given-names></name><name><surname>Armitage</surname><given-names>P.A.</given-names></name></person-group><article-title>A comparison of location of acute symptomatic versus &#x02018;silent&#x02019; small vessel lesions</article-title><source>Int J Stroke</source><volume>10</volume><year>2015</year><fpage>1044</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">26120782</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Debette</surname><given-names>S.</given-names></name><name><surname>Markus</surname><given-names>H.S.</given-names></name></person-group><article-title>The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis</article-title><source>BMJ</source><volume>341</volume><year>2010</year><fpage>c3666</fpage><pub-id pub-id-type="pmid">20660506</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Vermeer</surname><given-names>S.E.</given-names></name><name><surname>Longstreth</surname><given-names>W.T.</given-names><suffix>Jr.</suffix></name><name><surname>Koudstaal</surname><given-names>P.J.</given-names></name></person-group><article-title>Silent brain infarcts: a&#x000a0;systematic review</article-title><source>Lancet Neurol</source><volume>6</volume><year>2007</year><fpage>611</fpage><lpage>619</lpage><pub-id pub-id-type="pmid">17582361</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Cordonnier</surname><given-names>C.</given-names></name><name><surname>Al-Shahi Salman</surname><given-names>R.</given-names></name><name><surname>Wardlaw</surname><given-names>J.</given-names></name></person-group><article-title>Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting</article-title><source>Brain</source><volume>130</volume><year>2007</year><fpage>1988</fpage><lpage>2003</lpage><pub-id pub-id-type="pmid">17322562</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Staals</surname><given-names>J.</given-names></name><name><surname>Booth</surname><given-names>T.</given-names></name><name><surname>Morris</surname><given-names>Z.</given-names></name><name><surname>Bastin</surname><given-names>M.E.</given-names></name><name><surname>Gow</surname><given-names>A.J.</given-names></name><name><surname>Corley</surname><given-names>J.</given-names></name></person-group><article-title>Total MRI load of cerebral small vessel disease and cognitive ability in older people</article-title><source>Neurobiol Aging</source><volume>36</volume><year>2015</year><fpage>2806</fpage><lpage>2811</lpage><pub-id pub-id-type="pmid">26189091</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Snowdon</surname><given-names>D.A.</given-names></name><name><surname>Greiner</surname><given-names>L.H.</given-names></name><name><surname>Mortimer</surname><given-names>J.A.</given-names></name><name><surname>Riley</surname><given-names>K.P.</given-names></name><name><surname>Greiner</surname><given-names>P.A.</given-names></name><name><surname>Markesbery</surname><given-names>W.R.</given-names></name></person-group><article-title>Brain infarction and the clinical expression of Alzheimer disease. The Nun Study</article-title><source>JAMA</source><volume>277</volume><year>1997</year><fpage>813</fpage><lpage>817</lpage><pub-id pub-id-type="pmid">9052711</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>F.E.</given-names></name><name><surname>Brayne</surname><given-names>C.</given-names></name><name><surname>Lowe</surname><given-names>J.</given-names></name><name><surname>McKeith</surname><given-names>I.</given-names></name><name><surname>Wharton</surname><given-names>S.B.</given-names></name><name><surname>Ince</surname><given-names>P.</given-names></name></person-group><article-title>Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study</article-title><source>PLoS Med</source><volume>6</volume><year>2009</year><fpage>e1000180</fpage><pub-id pub-id-type="pmid">19901977</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Smallwood</surname><given-names>A.</given-names></name><name><surname>Oulhaj</surname><given-names>A.</given-names></name><name><surname>Joachim</surname><given-names>C.</given-names></name><name><surname>Christie</surname><given-names>S.</given-names></name><name><surname>Sloan</surname><given-names>C.</given-names></name><name><surname>Smith</surname><given-names>A.D.</given-names></name></person-group><article-title>Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort</article-title><source>Neuropathol Appl Neurobiol</source><volume>38</volume><year>2012</year><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">21951164</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Tosto</surname><given-names>G.</given-names></name><name><surname>Zimmerman</surname><given-names>M.E.</given-names></name><name><surname>Carmichael</surname><given-names>O.T.</given-names></name><name><surname>Brickman</surname><given-names>A.M.</given-names></name></person-group><article-title>Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities</article-title><source>JAMA Neurol</source><volume>71</volume><year>2014</year><fpage>872</fpage><lpage>877</lpage><pub-id pub-id-type="pmid">24821476</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>S.</given-names></name><name><surname>Matthews</surname><given-names>F.E.</given-names></name><name><surname>Barnes</surname><given-names>D.E.</given-names></name><name><surname>Yaffe</surname><given-names>K.</given-names></name><name><surname>Brayne</surname><given-names>C.</given-names></name></person-group><article-title>Potential for primary prevention of Alzheimer's disease: an analysis of population-based data</article-title><source>Lancet Neurol</source><volume>13</volume><year>2014</year><fpage>788</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">25030513</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Ngandu</surname><given-names>T.</given-names></name><name><surname>Lehtisalo</surname><given-names>J.</given-names></name><name><surname>Solomon</surname><given-names>A.</given-names></name><name><surname>Levalahti</surname><given-names>E.</given-names></name><name><surname>Ahtiluoto</surname><given-names>S.</given-names></name><name><surname>Antikainen</surname><given-names>R.</given-names></name></person-group><article-title>A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial</article-title><source>Lancet</source><volume>385</volume><year>2015</year><fpage>2255</fpage><lpage>2263</lpage><pub-id pub-id-type="pmid">25771249</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Sposato</surname><given-names>L.A.</given-names></name><name><surname>Kapral</surname><given-names>M.K.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Gill</surname><given-names>S.S.</given-names></name><name><surname>Hackam</surname><given-names>D.G.</given-names></name><name><surname>Cipriano</surname><given-names>L.E.</given-names></name></person-group><article-title>Declining incidence of stroke and dementia: coincidence or prevention opportunity?</article-title><source>JAMA Neurol</source><volume>72</volume><year>2015</year><fpage>1529</fpage><lpage>1531</lpage><pub-id pub-id-type="pmid">26658969</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>L.A.</given-names></name><name><surname>McClure</surname><given-names>L.A.</given-names></name><name><surname>Anderson</surname><given-names>D.C.</given-names></name><name><surname>Jacova</surname><given-names>C.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Hart</surname><given-names>R.G.</given-names></name></person-group><article-title>Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial</article-title><source>Lancet Neurol</source><volume>13</volume><year>2014</year><fpage>1177</fpage><lpage>1185</lpage><pub-id pub-id-type="pmid">25453457</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><collab>The SPS3 Investigators</collab></person-group><article-title>Effects of clopidogrel added to aspirin in patients with recent lacunar stroke</article-title><source>N Engl J Med</source><volume>367</volume><year>2012</year><fpage>817</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">22931315</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Thoonsen</surname><given-names>H.</given-names></name><name><surname>Richard</surname><given-names>E.</given-names></name><name><surname>Bentham</surname><given-names>P.</given-names></name><name><surname>Gray</surname><given-names>R.</given-names></name><name><surname>van Geloven</surname><given-names>N.</given-names></name><name><surname>De Haan</surname><given-names>R.J.</given-names></name></person-group><article-title>Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?</article-title><source>Stroke</source><volume>41</volume><year>2010</year><fpage>2690</fpage><lpage>2692</lpage><pub-id pub-id-type="pmid">20930165</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name><name><surname>Smith</surname><given-names>C.</given-names></name><name><surname>Dichgans</surname><given-names>M.</given-names></name></person-group><article-title>Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging</article-title><source>Lancet Neurol</source><volume>12</volume><year>2013</year><fpage>483</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">23602162</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Wharton</surname><given-names>S.B.</given-names></name><name><surname>Simpson</surname><given-names>J.E.</given-names></name><name><surname>Brayne</surname><given-names>C.</given-names></name><name><surname>Ince</surname><given-names>P.G.</given-names></name></person-group><article-title>Age-associated white matter lesions: The MRC Cognitive Function and Ageing Study</article-title><source>Brain Pathol</source><volume>25</volume><year>2015</year><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">25521175</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Bath</surname><given-names>P.M.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions</article-title><source>Int J Stroke</source><volume>10</volume><year>2015</year><fpage>469</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">25727737</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name><name><surname>Sandercock</surname><given-names>P.A.</given-names></name><name><surname>Dennis</surname><given-names>M.S.</given-names></name><name><surname>Starr</surname><given-names>J.</given-names></name></person-group><article-title>Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?</article-title><source>Stroke</source><volume>34</volume><year>2003</year><fpage>806</fpage><lpage>812</lpage></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>de la Torre</surname><given-names>J.</given-names></name></person-group><article-title>The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond</article-title><source>Neurodegener Dis</source><volume>7</volume><year>2010</year><fpage>116</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">20173340</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>E.L.</given-names></name><name><surname>Smith</surname><given-names>C.</given-names></name><name><surname>Sudlow</surname><given-names>C.L.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>Pathology of lacunar ischaemic stroke in humans&#x02014;a systematic review</article-title><source>Brain Pathol</source><volume>22</volume><year>2012</year><fpage>583</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">22329603</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Black</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>F.</given-names></name><name><surname>Bilbao</surname><given-names>J.</given-names></name></person-group><article-title>Understanding white matter disease. Imaging-pathological correlations in vascular cognitive impairment</article-title><source>Stroke</source><volume>40</volume><year>2009</year><fpage>S48</fpage><lpage>S52</lpage><pub-id pub-id-type="pmid">19064767</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Biron</surname><given-names>K.E.</given-names></name><name><surname>Dickstein</surname><given-names>D.L.</given-names></name><name><surname>Gopaul</surname><given-names>R.</given-names></name><name><surname>Jefferies</surname><given-names>W.A.</given-names></name></person-group><article-title>Amyloid triggers&#x000a0;extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease</article-title><source>PLoS One</source><volume>6</volume><year>2011</year><fpage>e23789</fpage><pub-id pub-id-type="pmid">21909359</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Kolstoe</surname><given-names>S.E.</given-names></name><name><surname>Ridha</surname><given-names>B.H.</given-names></name><name><surname>Bellotti</surname><given-names>V.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Robinson</surname><given-names>C.V.</given-names></name><name><surname>Crutch</surname><given-names>S.J.</given-names></name></person-group><article-title>Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component</article-title><source>Proc Natl Acad Sci U S A</source><volume>106</volume><year>2009</year><fpage>7619</fpage><lpage>7623</lpage><pub-id pub-id-type="pmid">19372378</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Farrall</surname><given-names>A.J.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>Blood brain barrier: ageing and microvascular disease&#x02014;systemic review and meta-analysis</article-title><source>Neurobiol Aging</source><volume>30</volume><year>2009</year><fpage>337</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">17869382</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>J.M.</given-names></name><name><surname>Wardlaw</surname><given-names>J.</given-names></name><name><surname>Ferguson</surname><given-names>K.</given-names></name><name><surname>MacLullich</surname><given-names>A.</given-names></name><name><surname>Deary</surname><given-names>I.J.</given-names></name><name><surname>Marshall</surname><given-names>I.</given-names></name></person-group><article-title>Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>74</volume><year>2003</year><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">12486269</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name><name><surname>Doubal</surname><given-names>F.</given-names></name><name><surname>Armitage</surname><given-names>P.</given-names></name><name><surname>Chappell</surname><given-names>F.</given-names></name><name><surname>Carpenter</surname><given-names>T.</given-names></name><name><surname>Maniega</surname><given-names>S.M.</given-names></name></person-group><article-title>Lacunar stroke is associated with diffuse blood-brain barrier dysfunction</article-title><source>Ann Neurol</source><volume>65</volume><year>2009</year><fpage>194</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">19260033</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Topakian</surname><given-names>R.</given-names></name><name><surname>Barrick</surname><given-names>T.R.</given-names></name><name><surname>Howe</surname><given-names>F.A.</given-names></name><name><surname>Markus</surname><given-names>H.S.</given-names></name></person-group><article-title>Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>81</volume><year>2010</year><fpage>192</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">19710048</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Taheri</surname><given-names>S.</given-names></name><name><surname>Gasparovic</surname><given-names>C.</given-names></name><name><surname>Huisa</surname><given-names>B.N.</given-names></name><name><surname>Adair</surname><given-names>J.C.</given-names></name><name><surname>Edmonds</surname><given-names>E.</given-names></name><name><surname>Prestopnik</surname><given-names>J.</given-names></name></person-group><article-title>Blood-brain barrier permeability abnormalities in vascular cognitive impairment</article-title><source>Stroke</source><volume>42</volume><year>2011</year><fpage>2158</fpage><lpage>2163</lpage><pub-id pub-id-type="pmid">21719768</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Kalaria</surname><given-names>R.N.</given-names></name></person-group><article-title>The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease</article-title><source>Ann N Y Acad Sci</source><volume>893</volume><year>1999</year><fpage>113</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">10672233</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>J.M.</given-names></name><name><surname>Farrall</surname><given-names>A.J.</given-names></name><name><surname>Armitage</surname><given-names>P.</given-names></name><name><surname>McGurn</surname><given-names>B.</given-names></name><name><surname>Wardlaw</surname><given-names>J.</given-names></name></person-group><article-title>Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study</article-title><source>Psychiatry Res</source><volume>171</volume><year>2009</year><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">19211227</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Montagne</surname><given-names>A.</given-names></name><name><surname>Barnes</surname><given-names>S.R.</given-names></name><name><surname>Sweeney</surname><given-names>M.D.</given-names></name><name><surname>Halliday</surname><given-names>M.R.</given-names></name><name><surname>Sagare</surname><given-names>A.P.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name></person-group><article-title>Blood-brain barrier breakdown in the aging human hippocampus</article-title><source>Neuron</source><volume>85</volume><year>2015</year><fpage>296</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">25611508</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Heye</surname><given-names>A.K.</given-names></name><name><surname>Culling</surname><given-names>R.D.</given-names></name><name><surname>Valdes Hernandez</surname><given-names>M.C.</given-names></name><name><surname>Thrippleton</surname><given-names>M.J.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>Assessment of blood&#x02013;brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review</article-title><source>Neuroimage Clin</source><volume>6</volume><year>2014</year><fpage>262</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">25379439</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Heye</surname><given-names>A.K.</given-names></name><name><surname>Thrippleton</surname><given-names>M.J.</given-names></name><name><surname>Armitage</surname><given-names>P.A.</given-names></name><name><surname>Valdes Hernandez</surname><given-names>M.C.</given-names></name><name><surname>Makin</surname><given-names>S.D.</given-names></name><name><surname>Glatz</surname><given-names>A.</given-names></name></person-group><article-title>Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability</article-title><source>Neuroimage</source><volume>125</volume><year>2016</year><fpage>446</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">26477653</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Maillard</surname><given-names>P.</given-names></name><name><surname>Seshadri</surname><given-names>S.</given-names></name><name><surname>Beiser</surname><given-names>A.</given-names></name><name><surname>Himali</surname><given-names>J.J.</given-names></name><name><surname>Au</surname><given-names>R.</given-names></name><name><surname>Fletcher</surname><given-names>E.</given-names></name></person-group><article-title>Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study</article-title><source>Lancet Neurol</source><volume>11</volume><year>2012</year><fpage>1039</fpage><lpage>1047</lpage><pub-id pub-id-type="pmid">23122892</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>C.A.</given-names></name><name><surname>Hutchison</surname><given-names>A.</given-names></name><name><surname>Dennis</surname><given-names>M.S.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name><name><surname>Lindgren</surname><given-names>A.</given-names></name><name><surname>Norrving</surname><given-names>B.</given-names></name></person-group><article-title>Differing risk factor profiles of ischemic stroke subtypes: evidence for a distinct lacunar arteriopathy?</article-title><source>Stroke</source><volume>41</volume><year>2010</year><fpage>624</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">20150553</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Bamford</surname><given-names>J.</given-names></name><name><surname>Sandercock</surname><given-names>P.</given-names></name><name><surname>Dennis</surname><given-names>M.</given-names></name><name><surname>Burn</surname><given-names>J.</given-names></name><name><surname>Warlow</surname><given-names>C.</given-names></name></person-group><article-title>Classification and natural history of clinically identifiable subtypes of cerebral infarction</article-title><source>Lancet</source><volume>337</volume><year>1991</year><fpage>1521</fpage><lpage>1526</lpage><pub-id pub-id-type="pmid">1675378</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Bamford</surname><given-names>J.</given-names></name><name><surname>Sandercock</surname><given-names>P.</given-names></name><name><surname>Dennis</surname><given-names>M.</given-names></name><name><surname>Burn</surname><given-names>J.</given-names></name><name><surname>Warlow</surname><given-names>C.</given-names></name></person-group><article-title>A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project&#x02014;1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage</article-title><source>J Neurol Neurosurg Psychiatry</source><volume>53</volume><year>1990</year><fpage>16</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">2303826</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Vald&#x000e9;s Hern&#x000e1;ndez</surname><given-names>M.</given-names></name><name><surname>Armitage</surname><given-names>P.</given-names></name><name><surname>Thrippleton</surname><given-names>M.J.</given-names></name><name><surname>Chappell</surname><given-names>F.</given-names></name><name><surname>Sandeman</surname><given-names>E.</given-names></name><name><surname>Munoz Maniega</surname><given-names>S.</given-names></name></person-group><article-title>Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke</article-title><source>Brain Behav</source><volume>5</volume><year>2015</year><fpage>e00415</fpage><pub-id pub-id-type="pmid">26807340</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name><name><surname>Smith</surname><given-names>E.E.</given-names></name><name><surname>Biessels</surname><given-names>G.J.</given-names></name><name><surname>Cordonnier</surname><given-names>C.</given-names></name><name><surname>Fazekas</surname><given-names>F.</given-names></name><name><surname>Frayne</surname><given-names>R.</given-names></name></person-group><article-title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach</article-title><source>Lancet Neurol</source><volume>12</volume><year>2013</year><fpage>822</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">23867200</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Armitage</surname><given-names>P.A.</given-names></name><name><surname>Farrall</surname><given-names>A.J.</given-names></name><name><surname>Carpenter</surname><given-names>T.K.</given-names></name><name><surname>Doubal</surname><given-names>F.N.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities</article-title><source>Magn Reson Imaging</source><volume>29</volume><year>2011</year><fpage>305</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">21030178</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name><name><surname>Bastin</surname><given-names>M.E.</given-names></name><name><surname>Valdes Hernandez</surname><given-names>M.C.</given-names></name><name><surname>Munoz Maniega</surname><given-names>S.</given-names></name><name><surname>Royle</surname><given-names>N.A.</given-names></name><name><surname>Morris</surname><given-names>Z.</given-names></name></person-group><article-title>Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol</article-title><source>Int J Stroke</source><volume>6</volume><year>2011</year><fpage>547</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">22111801</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Valdes Hernandez</surname><given-names>M.C.</given-names></name><name><surname>Ferguson</surname><given-names>K.J.</given-names></name><name><surname>Chappell</surname><given-names>F.M.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images</article-title><source>Eur Radiol</source><volume>20</volume><year>2010</year><fpage>1684</fpage><lpage>1691</lpage><pub-id pub-id-type="pmid">20157814</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Munoz Maniega</surname><given-names>S.</given-names></name><name><surname>Chappell</surname><given-names>F.M.</given-names></name><name><surname>Valdes Hernandez</surname><given-names>M.C.</given-names></name><name><surname>Armitage</surname><given-names>P.A.</given-names></name><name><surname>Makin</surname><given-names>S.D.</given-names></name><name><surname>Heye</surname><given-names>A.K.</given-names></name></person-group><article-title>Integrity of normal-appearing white matter: influence of age, visible lesion burden and hypertension in patients with small vessel disease</article-title><source>J Cereb Blood Flow Metab</source><volume>36</volume><year>2016</year><fpage>264</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">25899292</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Munoz Maniega</surname><given-names>S.</given-names></name><name><surname>Valdes Hernandez</surname><given-names>M.</given-names></name><name><surname>Clayden</surname><given-names>J.D.</given-names></name><name><surname>Royle</surname><given-names>N.A.</given-names></name><name><surname>Murray</surname><given-names>C.</given-names></name><name><surname>Morris</surname><given-names>Z.</given-names></name></person-group><article-title>White matter hyperintensities and normal-appearing white matter integrity in the aging brain</article-title><source>Neurobiol Aging</source><volume>36</volume><year>2015</year><fpage>909</fpage><pub-id pub-id-type="pmid">25457555</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>S.R.</given-names></name><name><surname>Ng</surname><given-names>T.S.</given-names></name><name><surname>Montagne</surname><given-names>A.</given-names></name><name><surname>Law</surname><given-names>M.</given-names></name><name><surname>Zlokovic</surname><given-names>B.V.</given-names></name><name><surname>Jacobs</surname><given-names>R.E.</given-names></name></person-group><article-title>Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI</article-title><source>Magn Reson Med</source><volume>75</volume><year>2016</year><fpage>1967</fpage><lpage>1977</lpage><pub-id pub-id-type="pmid">26077645</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Heye</surname><given-names>A.K.</given-names></name><name><surname>Thrippleton</surname><given-names>M.J.</given-names></name><name><surname>Chappell</surname><given-names>F.M.</given-names></name><name><surname>Valdes Hernandez</surname><given-names>M.C.</given-names></name><name><surname>Armitage</surname><given-names>P.A.</given-names></name><name><surname>Makin</surname><given-names>S.D.</given-names></name></person-group><article-title>Blood pressure and sodium: association with MRI markers in cerebral small vessel disease</article-title><source>J Cereb Blood Flow Metab</source><volume>36</volume><year>2016</year><fpage>264</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">25899292</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><collab>SPS3 Study Group</collab><name><surname>Benavente</surname><given-names>O.R.</given-names></name><name><surname>Coffey</surname><given-names>C.S.</given-names></name><name><surname>Conwit</surname><given-names>R.</given-names></name><name><surname>Hart</surname><given-names>R.G.</given-names></name><name><surname>McClure</surname><given-names>L.A.</given-names></name></person-group><article-title>Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial</article-title><source>Lancet</source><volume>382</volume><year>2013</year><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">23726159</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Maillard</surname><given-names>P.</given-names></name><name><surname>Fletcher</surname><given-names>E.</given-names></name><name><surname>Lockhart</surname><given-names>S.N.</given-names></name><name><surname>Roach</surname><given-names>A.E.</given-names></name><name><surname>Reed</surname><given-names>B.</given-names></name><name><surname>Mungas</surname><given-names>D.</given-names></name></person-group><article-title>White matter hyperintensities and their penumbra lie along a continuum of injury in the aging brain</article-title><source>Stroke</source><volume>45</volume><year>2014</year><fpage>1721</fpage><lpage>1726</lpage><pub-id pub-id-type="pmid">24781079</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Huisa</surname><given-names>B.N.</given-names></name><name><surname>Caprihan</surname><given-names>A.</given-names></name><name><surname>Thompson</surname><given-names>J.</given-names></name><name><surname>Prestopnik</surname><given-names>J.</given-names></name><name><surname>Qualls</surname><given-names>C.R.</given-names></name><name><surname>Rosenberg</surname><given-names>G.A.</given-names></name></person-group><article-title>Long-term blood-brain barrier permeability changes in Binswanger disease</article-title><source>Stroke</source><volume>46</volume><year>2015</year><fpage>2413</fpage><lpage>2418</lpage><pub-id pub-id-type="pmid">26205374</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Lammie</surname><given-names>G.A.</given-names></name><name><surname>Brannan</surname><given-names>F.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>Incomplete lacunar infarction (type 1b lacunes)</article-title><source>Acta Neuropathol</source><volume>96</volume><year>1998</year><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">9705132</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>A.</given-names></name><name><surname>Akinyemi</surname><given-names>R.O.</given-names></name><name><surname>Hase</surname><given-names>Y.</given-names></name><name><surname>Firbank</surname><given-names>M.J.</given-names></name><name><surname>Ndung'u</surname><given-names>M.N.</given-names></name><name><surname>Foster</surname><given-names>V.</given-names></name></person-group><article-title>Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia</article-title><source>Brain</source><volume>139</volume><year>2016</year><fpage>242</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">26667280</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>S.T.</given-names></name><name><surname>Jack</surname><given-names>C.R.</given-names></name><name><surname>Fornage</surname><given-names>M.</given-names></name><name><surname>Mosley</surname><given-names>T.H.</given-names></name><name><surname>Boerwinkle</surname><given-names>E.</given-names></name><name><surname>de Andrade</surname><given-names>M.</given-names></name></person-group><article-title>Heritability of leukoaraiosis in hypertensive sibships</article-title><source>Hypertension</source><volume>43</volume><year>2004</year><fpage>483</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">14718359</pub-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Verhaaren</surname><given-names>B.F.</given-names></name><name><surname>Debette</surname><given-names>S.</given-names></name><name><surname>Bis</surname><given-names>J.C.</given-names></name><name><surname>Smith</surname><given-names>J.A.</given-names></name><name><surname>Ikram</surname><given-names>M.K.</given-names></name><name><surname>Adams</surname><given-names>H.H.</given-names></name></person-group><article-title>Multi-ethnic genome-wide association study of cerebral white matter hyperintensities on MRI</article-title><source>Circ Cardiovasc Genet</source><volume>8</volume><year>2015</year><fpage>398</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">25663218</pub-id></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>L.</given-names></name><name><surname>Hill</surname><given-names>W.D.</given-names></name><name><surname>Harris</surname><given-names>S.E.</given-names></name><name><surname>Valdes Hernandez</surname><given-names>M.</given-names></name><name><surname>Munoz Maniega</surname><given-names>S.</given-names></name><name><surname>Bastin</surname><given-names>M.E.</given-names></name></person-group><article-title>Genes from a translational analysis support a multifactorial nature of white matter hyperintensities</article-title><source>Stroke</source><volume>46</volume><year>2015</year><fpage>341</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">25586835</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>S.F.</given-names></name><name><surname>Doubal</surname><given-names>F.N.</given-names></name><name><surname>Shuler</surname><given-names>K.</given-names></name><name><surname>Wardlaw</surname><given-names>J.M.</given-names></name></person-group><article-title>A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls</article-title><source>Stroke</source><volume>41</volume><year>2010</year><fpage>e434</fpage><lpage>e442</lpage><pub-id pub-id-type="pmid">20395619</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supplementary data</title><p><supplementary-material content-type="local-data" id="ec1"><caption><title>Supplementary Data</title></caption><media xlink:href="mmc1.doc"/></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>We thank the participants, their relatives, and carers for their time and patience in contributing to the study, the staff of NHS Lothian Stroke Services, and the Brain Research Imaging Centre Edinburgh for their assistance in recruiting and assessing the patients. Funding: Wellcome Trust (WT088134/Z/09/A), Row Fogo Charitable Trust, Scottish Funding Council Scottish Imaging Network A Platform for Scientific Excellence collaboration, Age-UK Disconnected Mind Study, NHS Lothian R+D Department, and The Brain Research Imaging Centre Edinburgh (<ext-link ext-link-type="uri" xlink:href="http://www.sbirc.ed.ac.uk/" id="interref0010">http://www.sbirc.ed.ac.uk/</ext-link>). Conflict of interest: All authors report grants from <funding-source id="gs1">Wellcome Trust</funding-source>, grants from <funding-source id="gs2">Row Fogo Charitable Trust</funding-source>, grants from <funding-source id="gs3">Age UK</funding-source>, and grants from <funding-source id="gs4">Scottish Funding Council</funding-source>, during the conduct of the study. Role of the funding source: The funders had no role in the planning, execution, analysis of the study, or preparation of the manuscript or decision to submit. The authors hold the data.</p></ack><fn-group><fn id="appsec2" fn-type="supplementary-material"><p>Supplementary data related to this article can be found at <ext-link ext-link-type="doi" xlink:href="10.1016/j.jalz.2016.09.006" id="intref0020">http://dx.doi.org/10.1016/j.jalz.2016.09.006</ext-link>.</p></fn></fn-group></back></article>